# Adocia clinical trials: 27 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 27 trials with Adocia as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Adocia: 27 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/adocia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 27
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 27, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 13, 2022 | NCT05373212 | A Trial Investigating the Dose Linearity and Safety of BC Combo THDB0207 in Subjects With Type 2 Diabetes | Adocia | Phase 1 | Completed | Type 2 Diabetes | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05373212) |
| May 13, 2022 | NCT05373199 | A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes | Adocia | Phase 1 | Completed | Type 1 Diabetes | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05373199) |
| May 13, 2022 | NCT05373186 | A Trial Investigating the Pharmacodynamics of BC Combo THDB0207 Compared With Humalog® Mix25 and Simultaneous Injections of Humalog® and... | Adocia | Phase 1 | Completed | Healthy | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05373186) |
| March 25, 2021 | NCT04816890 | A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM) | Adocia | Phase 2 | Completed | Type 1 Diabetes Mellitus | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04816890) |
| August 6, 2020 | NCT04501107 | A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1... | Adocia | Phase 1 | Completed | Type 1 Diabetes | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04501107) |
| June 11, 2019 | NCT03981627 | A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus | Adocia | Phase 1/2 | Completed | Type 1 Diabetes Mellitus | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03981627) |
| April 16, 2019 | NCT03916640 | A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus | Adocia | Phase 1 | Completed | Type 1 Diabetes Mellitus | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03916640) |
| April 30, 2018 | NCT03512236 | A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With... | Adocia | Phase 1 | Completed | Type 1 Diabetes Mellitus | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03512236) |
| June 8, 2017 | NCT03180710 | A Trial to Investigate the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2... | Adocia | Phase 1 | Completed | Type 2 Diabetes Mellitus | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03180710) |
| June 7, 2017 | NCT03179332 | A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by... | Adocia | Phase 1 | Completed | Type1 Diabetes Mellitus | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03179332) |
| June 5, 2017 | NCT03176524 | A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations... | Adocia | Phase 1 | Completed | Type 1 Diabetes Mellitus | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03176524) |
| September 26, 2016 | NCT02915250 | A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of... | Adocia | Phase 1 | Completed | Type 2 Diabetes Mellitus | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02915250) |
| April 15, 2016 | NCT02739906 | A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®)... | Adocia | Phase 1/2 | Completed | Type 1 Diabetes Mellitus | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02739906) |
| January 21, 2016 | NCT02660502 | An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects | Adocia | Phase 1 | Completed | Healthy | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02660502) |
| September 29, 2015 | NCT02562326 | A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog®... | Adocia | Phase 1 | Completed | Type 2 Diabetes Mellitus | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02562326) |
| September 29, 2015 | NCT02562313 | A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to... | Adocia | Phase 1 | Completed | Type 1 Diabetes Mellitus | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02562313) |
| August 20, 2015 | NCT02529293 | A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100... | Adocia | Phase 1 | Completed | Healthy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02529293) |
| August 19, 2015 | NCT02528396 | To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients... | Adocia | Phase 1 | Completed | Type 1 Diabetes Mellitus | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02528396) |
| August 4, 2015 | NCT02514954 | Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus | Adocia | Phase 1 | Completed | Type 1 Diabetes Mellitus | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02514954) |
| August 4, 2015 | NCT02514850 | A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous... | Adocia | Phase 1 | Completed | Type 2 Diabetes Mellitus | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02514850) |
| January 26, 2015 | NCT02344992 | Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal | Adocia | Phase 1 | Completed | Diabetes Mellitus Type 1 | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02344992) |
| September 11, 2014 | NCT02236793 | A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer | Adocia | Phase 3 | Completed | Diabetic Foot Ulcer | 252 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02236793) |
| August 11, 2014 | NCT02213146 | A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety... | Adocia | Phase 1/2 | Completed | Diabetes Mellitus Type 1 | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02213146) |
| May 26, 2014 | NCT02146651 | A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship... | Adocia | Phase 2 | Completed | Diabetes Mellitus Type 1 | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02146651) |
| January 8, 2014 | NCT02029924 | A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of... | Adocia | Phase 1 | Completed | Diabetes Mellitus Type 1 | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02029924) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 21 |
| Phase 1/2 | 3 |
| Phase 2 | 2 |
| Phase 3 | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 27 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus, Type 1 | 16 |
| Diabetes Mellitus, Type 2 | 5 |
| Diabetes Mellitus | 1 |
| Diabetic Foot | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Appliance manufacturers in the United States](https://specstream.ai/data/businesses/appliance-manufacturers/united-states)
- [Egyptian restaurants in the United States](https://specstream.ai/data/businesses/egyptian-restaurants/united-states)
- [Mediators in the United States](https://specstream.ai/data/businesses/mediators/united-states)
- [Surgery centers in the United States](https://specstream.ai/data/businesses/surgery-centers/united-states)
- [Buffet restaurants in the United States](https://specstream.ai/data/businesses/buffet-restaurants/united-states)
- [Greek restaurants in the United States](https://specstream.ai/data/businesses/greek-restaurants/united-states)
